Literature DB >> 29782641

The analgesic efficacy and pharmacokinetics of epidural oxycodone after gynaecological laparotomy: a randomized, double-blind, double-dummy comparison with intravenous administration.

Panu Piirainen1, Hannu Kokki1,2, Heidi Hautajärvi3, Veli-Pekka Ranta4, Merja Kokki2.   

Abstract

AIM: The aim of the present study was to compare the analgesic efficacy of epidural and intravenous (i.v.) oxycodone at the same dose.
METHODS: In this randomized, double-blind, double-dummy clinical trial, 30 women, aged 24-67 years, undergoing elective gynaecological laparotomy, were administrated either i.v. saline and epidural oxycodone 0.1 mg·kg-1 (EPI group; n = 15) or i.v. oxycodone 0.1 mg·kg-1 and epidural saline (IV group; n = 15). For multimodal analgesia, patients received i.v. paracetamol and dexketoprofen, and a triple-mixture epidural infusion after the first 4 h postoperatively. The primary outcome was the total dose of i.v. fentanyl for rescue analgesia during the first 4 h postoperatively.
RESULTS: All patients required fentanyl during the first 4 h. The median number of fentanyl doses were three (quartiles 1, 8) in the EPI group and seven (6, 9) in the IV group (mean difference 3.1; 95% confidence interval 0.9, 5.2; P = 0.01). After the first 4 h, the two groups needed a similar total dose of epidural infusion. Patient satisfaction was similarly high in both groups, and both administration routes were well tolerated.
CONCLUSIONS: The data support the superiority of epidural oxycodone compared with that of i.v. administration in pain management after laparotomy.
© 2018 The British Pharmacological Society.

Entities:  

Keywords:  analgesia; epidural; laparotomy; oxycodone

Mesh:

Substances:

Year:  2018        PMID: 29782641      PMCID: PMC6089810          DOI: 10.1111/bcp.13643

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  22 in total

1.  Analgesic concentrations of oxycodone--a prospective clinical PK/PD study in patients with laparoscopic cholecystectomy.

Authors:  Merja Kokki; Susanna Broms; Matti Eskelinen; Ilpo Rasanen; Ilkka Ojanperä; Hannu Kokki
Journal:  Basic Clin Pharmacol Toxicol       Date:  2011-12-29       Impact factor: 4.080

2.  Comparison of epidural morphine and oxycodone for pain after abdominal surgery.

Authors:  M Backlund; L Lindgren; Y Kajimoto; P H Rosenberg
Journal:  J Clin Anesth       Date:  1997-02       Impact factor: 9.452

3.  Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats.

Authors:  Kim K Lemberg; Vesa K Kontinen; Antti O Siiskonen; Kaarin M Viljakka; Jari T Yli-Kauhaluoma; Esa R Korpi; Eija A Kalso
Journal:  Anesthesiology       Date:  2006-10       Impact factor: 7.892

4.  Intravenous morphine and oxycodone for pain after abdominal surgery.

Authors:  E Kalso; R Pöyhiä; P Onnela; K Linko; I Tigerstedt; T Tammisto
Journal:  Acta Anaesthesiol Scand       Date:  1991-10       Impact factor: 2.105

5.  A randomized double-blind comparison of epidural versus intravenous fentanyl infusion for analgesia after thoracotomy.

Authors:  T E Salomäki; J O Laitinen; L S Nuutinen
Journal:  Anesthesiology       Date:  1991-11       Impact factor: 7.892

6.  Pharmacological characterization of noroxymorphone as a new opioid for spinal analgesia.

Authors:  Kim K Lemberg; Antti O Siiskonen; Vesa K Kontinen; Jari T Yli-Kauhaluoma; Eija A Kalso
Journal:  Anesth Analg       Date:  2008-02       Impact factor: 5.108

7.  Central nervous system penetration of oxycodone after intravenous and epidural administration.

Authors:  M Kokki; P Välitalo; M Kuusisto; V P Ranta; K Raatikainen; H Hautajärvi; H Kokki
Journal:  Br J Anaesth       Date:  2013-10-16       Impact factor: 9.166

8.  Comparison of epidural oxycodone and epidural morphine for post-caesarean section analgesia: A randomised controlled trial.

Authors:  Ban Leong Sng; Sarah Carol Kwok; Deepak Mathur; Farida Ithnin; Clare Newton-Dunn; Pryseley Nkouibert Assam; Rehena Sultana; Alex Tiong Heng Sia
Journal:  Indian J Anaesth       Date:  2016-03

9.  Cytotoxicity of Oxycodone and Morphine in Human Neuroblastoma and Mouse Motoneuronal Cells: A Comparative Approach.

Authors:  Merja Kokki; Maija Pesonen; Piia Vehviläinen; Outi Litmala; Markku Pasanen; Hannu Kokki
Journal:  Drugs R D       Date:  2016-06

10.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.

Authors:  Simon D Harding; Joanna L Sharman; Elena Faccenda; Chris Southan; Adam J Pawson; Sam Ireland; Alasdair J G Gray; Liam Bruce; Stephen P H Alexander; Stephen Anderton; Clare Bryant; Anthony P Davenport; Christian Doerig; Doriano Fabbro; Francesca Levi-Schaffer; Michael Spedding; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

View more
  4 in total

1.  Analgesic efficacy and pharmacokinetics of epidural oxycodone in pain management after gynaecological laparoscopy-A randomised, double blind, active control, double-dummy clinical comparison with intravenous administration.

Authors:  Panu Piirainen; Hannu Kokki; Brian Anderson; Jacqueline Hannam; Heidi Hautajärvi; Veli-Pekka Ranta; Merja Kokki
Journal:  Br J Clin Pharmacol       Date:  2019-06-20       Impact factor: 4.335

Review 2.  Updated Clinical Pharmacokinetics and Pharmacodynamics of Oxycodone.

Authors:  Mari Kinnunen; Panu Piirainen; Hannu Kokki; Pauliina Lammi; Merja Kokki
Journal:  Clin Pharmacokinet       Date:  2019-06       Impact factor: 6.447

Review 3.  Epidural Oxycodone for Acute Pain.

Authors:  Panu Piirainen; Hannu Kokki; Merja Kokki
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-23

4.  Oxycodone vs Sufentanil in Patient-Controlled Intravenous Analgesia After Gynecological Tumor Operation: A Randomized Double-Blind Clinical Trial.

Authors:  Sha-Jie Dang; Rui-Li Li; Jun Wang; Wen-Bin Zeng; Yun He; Hui-Yu Yue; Si-Yuan Li; Li-Chun Han
Journal:  J Pain Res       Date:  2020-05-05       Impact factor: 3.133

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.